Gluz, O.; Nitz, U.; Christgen, M.; Kates, R.; Clemens, M.; Nuding, B.; Shak, S.; Würstlein, R.; Kreipe, H. und Harbeck, N.
(2017):
Five-year results of the prospective Phase III WSG PlanB trial confirm prognostic impact of 21-Gene Recurrence Score in high-risk HR+/HER2-early breast cancer (EBC) patients with 1-3 involved lymph nodes.
In: Breast, Vol. 32: S93-S93
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0960-9776 |
| Language: | English |
| Item ID: | 55074 |
| Date Deposited: | 14. Jun 2018 09:58 |
| Last Modified: | 04. Nov 2020 13:35 |
Actions (login required)
- View Item
